In this presentation from the JAK Inhibitors in Myeloproliferative Neoplasms symposium, held August 27, 2016 in Alexandria, VA, Dr. Srdan Verstovsek examines a case of inadequately-controlled polycythemia vera (PV).
Case study: Inadequately controlled Polycythemia Vera (PV)
